4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000127
Options or other derivatives
- SVP, Chief Financial Officer acquired 163,666 shares (grant or award)
- SVP, Chief Financial Officer returned 163,666 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Branning Todd P. SVP, Chief Financial Officer | 2019-11-13 | Returned to the company · Stock Option | −163,666 | 0 | D: show line 1 in the form | |||||
| Branning Todd P. SVP, Chief Financial Officer | 2019-11-13 | Grant or award · Stock Option | +163,666 | 163,666 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_157377035410885.xml…